Sangui Biotech International, Inc. filed its 10-K on Sep 28, 2022 for the period ending Jun 30, 2022. In this report its auditor, Sadler, Gibb and Associates, LLC, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.002 EUR | -20.00% | -.--% | -33.33% |
1st Jan change | Capi. | |
---|---|---|
-33.33% | 448K | |
+1.51% | 42.75B | |
+8.57% | 41.34B | |
+49.22% | 41.61B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- SBH Stock
- News Sangui Biotech International, Inc.
- Sangui Biotech International, Inc. Auditor Raises 'Going Concern' Doubt